Revance Specifies 2016 Clinical Program Milestones
Jan 07, 2016 21:05 pm UTC| Business
NEWARK, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (NASDAQ:RVNC), a specialty biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications,...
AppliedMicro to Host Fiscal Third Quarter 2016 Earnings Conference Call on January 28, 2016
Jan 07, 2016 21:05 pm UTC| Business
SANTA CLARA, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Applied Micro Circuits Corporation, or AppliedMicro (Nasdaq:AMCC), announced today that it will release operating results for its fiscal 2016 third quarter after the...
LinkedIn Announces Webcast of Fourth Quarter and Full Year 2015 Business Results
Jan 07, 2016 21:05 pm UTC| Business
MOUNTAIN VIEW, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- LinkedIn (NYSE:LNKD), the world's largest professional network on the Internet, today announced that it will host a conference call to discuss its fourth quarter ...
Varonis to Present at the Needham Growth Conference
Jan 07, 2016 21:05 pm UTC| Business
NEW YORK, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (NASDAQ:VRNS), the leading provider of software solutions for unstructured, human-generated enterprise data, today announced that Chief Executive Officer...
Rapid7 to Report Fourth Quarter and Full Year 2015 Financial Results on February 10
Jan 07, 2016 21:05 pm UTC| Business
BOSTON, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ:RPD), a leading provider of security data and analytics solutions, today announced that it will release its fourth quarter and full year 2015 financial...
Qorvo® Revises Revenue Guidance For Fiscal 2016 Third Quarter
Jan 07, 2016 21:01 pm UTC| Business
GREENSBORO, N.C. and HILLSBORO, Ore., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq:QRVO), a leading provider of core technologies and RF solutions for mobile, infrastructure and aerospace/defense applications, today...
AngioDynamics Reports Fiscal 2016 Second Quarter Results
Jan 07, 2016 21:01 pm UTC| Business
Net sales of $89.2 million GAAP loss of $0.01 per share; Non-GAAP adjusted EPS of $0.14Operating cash generation of $9.6 million ALBANY, N.Y., Jan. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading...